HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PD 068235

inhibits rosiglitazone-dependent PPARgamma transcriptional activity

Also Known As:

PD-068235; PD068235

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - PD 068235: 1
- Nitro Compounds: 66
  - PD 068235: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - PD 068235: 1

Experts

1.	Desbordes, Charles: 1 article (09/2004)
2.	Lea, Michael A: 1 article (09/2004)
3.	Sura, Monali: 1 article (09/2004)

Related Diseases

1.	Acute Erythroblastic Leukemia (Erythroleukemia) 09/01/2004 - "Proliferation of DS19 mouse erythroleukemia cells was inhibited by PPAR gamma agonists (4-phenylbutyrate, rosiglitazone, ciglitazone and GW1929) and by potential PPAR gamma antagonists: BADGE (Biphenol A diglycidyl ether), GW9662, PD068235 and diclofenac. "

Related Drugs and Biologics

1.	PPAR gamma
2.	Ether (Diethyl Ether)
3.	Diclofenac (SR 38)
4.	PPAR-gamma Agonists
5.	Rosiglitazone (Avandia)
6.	2-chloro-5-nitrobenzanilide
7.	GW 1929
8.	ciglitazone